Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

4463 ARTíCULOS , VIENDO DEL 4216 AL 4230

PUBMED

RNA toxicity induced by expanded CAG repeats in Huntington's disease.

Martí E.

Brain Pathol. 2016 Nov;26(6):779-786. doi: 10.1111/bpa.12427.

0

0

0

PUBMED

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.

Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, Frost C, Langbehn DR; TRACK-HD inves

Lancet Neurol. 2012 Jan;11(1):42-53. doi: 10.1016/S1474-4422(11)70263-0.

0

0

0

PUBMED

Indoleamine 2,3-dioxygenase as a novel therapeutic target for Huntington's disease.

Boros FA, Klivényi P, Toldi J, Vécsei L.

Expert Opin Ther Targets. 2018 Nov 22:1-13. doi: 10.1080/14728222.2019.1549231. [Epub ahead of print]

0

0

0

PUBMED

Promising compound targets mitochondria in Huntington's disease.

Parks L.

Future Med Chem. 2013 Jan;5(1):18. No abstract available.

0

0

0

PUBMED

Investigational drugs for the management of Huntington's disease: are we there yet?

Kulkarni P, Saxena U.

Expert Opin Investig Drugs. 2014 Dec;23(12):1595-603. doi: 10.1517/13543784.2014.934807. Review.

0

0

0

PUBMED

Early Neurodegeneration in R6/2 Mice Carrying the Huntington's Disease Mutation with a Super-Expanded CAG Repeat, Despite Normal Lifespan.

Kielar C, Jennifer Morton A.

J Huntingtons Dis. 2018;7(1):61-76. doi: 10.3233/JHD-170265.

0

0

0

PUBMED

Anesthetic management of patients with Huntington disease.

Kivela JE, Sprung J, Southorn PA, Watson JC, Weingarten TN.

Anesth Analg. 2010 Feb 1;110(2):515-23. doi: 10.1213/ANE.0b013e3181c88fcd.

0

0

0

PUBMED

Family caregivers' experiences with healthcare services - a case of Huntington disease.

Domaradzki J.

Psychiatr Pol. 2016;50(2):375-391. doi: 10.12740/PP/59103. English, Polish.

0

0

0

PUBMED

Gintonin, a ginseng-derived ingredient, as a novel therapeutic strategy for Huntington's disease: Activation of the Nrf2 pathway through lysophosphatidic acid receptors.

Jang M, Choi JH, Chang Y, Lee SJ, Nah SY, Cho IH.

Brain Behav Immun. 2019 Mar 7. pii: S0889-1591(18)30392-1. doi: 10.1016/j.bbi.2019.03.001. [Epub ahead of print]

0

0

0

PUBMED

The role of dopamine and glutamate modulation in Huntington disease.

Mittal SK, Eddy C.

Behav Neurol. 2013;26(4):255-63. doi: 10.3233/BEN-2012-120268. Review.

0

0

0

PUBMED

Phenomenology and disease progression of chorea-acanthocytosis patients in Spain.

Estévez-Fraga C, López-Sendón Moreno JL, Martínez-Castrillo JC; Spanish Collaborative Neuroacanthocytosis Group..

Parkinsonism Relat Disord. 2018 Apr;49:17-21. doi: 10.1016/j.parkreldis.2017.10.016. Epub 2017 Dec 20. No abstract available.

0

0

0

PUBMED

A New VMAT-2 Inhibitor NBI-641449 in the Treatment of Huntington Disease.

Chen S, Zhang XJ, Xie WJ, Qiu HY, Liu H, Le WD.

CNS Neurosci Ther. 2015 Aug;21(8):662-71. doi: 10.1111/cns.12425.

0

0

0

PUBMED

Partial Amelioration of Peripheral and Central Symptoms of Huntington's Disease via Modulation of Lipid Metabolism.

Chen JY, Tran C, Hwang L, Deng G, Jung ME, Faull KF, Levine MS, Cepeda C.

J Huntingtons Dis. 2016;5(1):65-81. doi: 10.3233/JHD-150181.

0

0

0

PUBMED

Huntington's disease presenting as posterior cortical atrophy.

Caixeta L.

Arq Neuropsiquiatr. 2011;69(2B):407-8. No abstract available.

0

0

0

PUBMED

Music perception and movement deterioration in Huntington's disease.

Beste C, Schüttke A, Pfleiderer B, Saft C.

PLoS Curr. 2011 Sep 20;3:RRN1252. doi: 10.1371/currents.RRN1252.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy